|
|
Volumn 35, Issue 12, 2000, Pages 1288-1293
|
|
Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
Chronic hepatitis C; Neutralizing anti interferon antibody
|
|
Indexed keywords
INTERFERON;
INTERFERON ANTIBODY;
LYMPHOBLAST INTERFERON;
LYMPHOBLAST INTERFERON ALPHA N1;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RNA;
UNCLASSIFIED DRUG;
ADULT;
AGE;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANTIBODY DETECTION;
ANTIBODY PRODUCTION;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
GENDER;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HISTOPATHOLOGY;
HUMAN;
INCIDENCE;
LIVER;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TAIWAN;
TREATMENT OUTCOME;
VIREMIA;
VIRUS LOAD;
ADULT;
ANTIBODIES;
ANTIVIRAL AGENTS;
FEMALE;
GENOTYPE;
HEPATITIS C;
HEPATITIS C ANTIBODIES;
HEPATITIS C, CHRONIC;
HUMANS;
INCIDENCE;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
INTERFERON TYPE I;
INTERFERON-ALPHA;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
NEUTRALIZATION TESTS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, VIRAL;
TAIWAN;
VIREMIA;
|
|
EID: 0034524239
PISSN: 00365521
EISSN: None
Source Type: Journal
DOI: 10.1080/003655200453647 Document Type: Article |
|
Times cited : (15)
|
|
References (31)
|
